Prognostic

The Prognostic Value of Plasma YKL-40 in Patients With Chemotherapy-Resistant Ovarian Cancer Treated With Bevacizumab
Mogens K. Boisen, Christine V. Madsen, Christian Dehlendorff, Anders Jakobsen, Julia S. Johansen, Karina D. Steffensen

International Journal of Gynecologic Cancer Oct 2016, 26 (8) 1390-1398; DOI: 10.1097/IGC.0000000000000798
Ovarian Yolk Sac Tumors; Does Age Matter?
Cecile Faure Conter, Caihong Xia, David Gershenson, Jean Hurteau, Al Covens, Farzana Pashankar, Mark Krailo, Deborah Billmire, Catherine Patte, Brice Fresneau, Furqan Shaikh, Sara Stoneham, James Nicholson, Matthew Murray, Anne Lindsay Frazier

International Journal of Gynecologic Cancer Jan 2018, 28 (1) 77-84; DOI: 10.1097/IGC.0000000000001149
Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in a Multi-institutional Cohort of 165 Cases
Eman Abdulfatah, Sharif Sakr, Sumi Thomas, Zaid Al-Wahab, David G. Mutch, Sean Dowdy, Sudeshna Bandyopadhyay, Adnan Munkarah, Mohamed Elshaikh, Robert Morris, Rouba Ali-Fehmi

International Journal of Gynecologic Cancer Oct 2017, 27 (8) 1714-1721; DOI: 10.1097/IGC.0000000000001050
The Use of Lymph Vessel Markers to Predict Endometrial Cancer Outcome
Ingrid Vandenput, Thomas Vanhove, Ben Van Calster, Toon Van Gorp, Philippe Moerman, Godelieve Verbist, Ignace Vergote, Frédéric Amant

International Journal of Gynecologic Cancer Apr 2010, 20 (3) 363-367; DOI: 10.1111/IGC.0b013e3181d4a0b9
Report of an unusual problematic uterine smooth muscle neoplasm, emphasizing the prognostic importance of coagulative tumor cell necrosis
F. AMANT, P. MOERMAN, I. VERGOTE

International Journal of Gynecologic Cancer Nov 2005, 15 (6) 1210-1212; DOI: 10.1136/ijgc-00009577-200511000-00042

Log in using your username and password

Main menu

Log in using your username and password

You are here

Prognostic